Role and Regulation of a Molecular Mimic in Histoplasma Pathogenesis
分子模拟物在组织胞浆菌发病机制中的作用和调节
基本信息
- 批准号:8281120
- 负责人:
- 金额:$ 18.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntifungal AgentsAntigen PresentationAntigen Presentation PathwayApplications GrantsAttentionBinding ProteinsBiological ModelsBiologyBlastomyces dermatitidisCD1 AntigensCREB-binding proteinCellsClimateCollectionComplement Factor HDNA SequenceDataDefectDevelopmentDiseaseFutureGene Expression RegulationGene ProteinsGenesGeographic DistributionGoalsHaploidyHistoplasmaHistoplasma capsulatumHistoplasmosisHomologous GeneHousingHumanHuman PathologyImmuneImmune responseImmunocompromised HostIn VitroInfectionInsertional MutagenesisLibrariesLipid BindingLipidsLocationLungLysosomesMammalsMembraneMoldsMolecularMolecular GeneticsMusNutrientOrganismPathogenesisPenicilliumPhagolysosomePhagosomesPhasePolysaccharidesProliferatingProtein FamilyProteinsRecording of previous eventsRegulationRegulator GenesResearchResolutionRespiratory Tract InfectionsRoleSaposinsSoilSolutionsSphingolipid Activator Protein-1SporothrixStructural GenesStructureStudy modelsSystemic diseaseTemperatureTestingTranscriptional RegulationVirulenceVirulence FactorsWorkYeastsZoonosesbasedesignfungusin vivoinhibitor/antagonistinterestintracellular parasitismmacrophagemembermutantnovelpathogenresearch studythree dimensional structuretool
项目摘要
DESCRIPTION (provided by applicant): Histoplasma capsulatum is one of the classic "dimorphic" fungal pathogens, undergoing a temperature-induced transition from a mold form that grows in soil to a yeast form that establishes infection in lung macrophages. All of the dimorphic fungi cause the most severe disease in immunocompromised patients, but they are primary pathogens that can cause serious problems in hosts lacking any demonstrable immune defect. The first genetically proven virulence factor of H. capsulatum was CBP, a yeast phase-specific secreted protein that is important for proliferation within macrophages in vitro and in vivo. Solving the three-dimensional structure of CBP revealed a surprising similarity to saposin B, a mammalian protein involved in membrane processing and antigen presentation. Although the structural homology is strongly suggestive that CBP is the first identified fungal member of the large and diverse saposin-like protein family, its precise mechanistic role in histoplasmosis remains unproven. This grant application is designed to evaluate whether CBP indeed functions as a saposin and to understand the basis for CBP1 phase-specific regulation: Specific Aim 1. Define the saposin-like function of CBP. The studies in this Aim will first test whether CBP functions like a saposin in terms of binding lipids, either fungal or mammalian, and will include a
structure-function analysis to determine which residues of CBP are involved. The potential role of CBP in CD1 antigen presentation, analogous to the function of saposin B, will also be explored. Specific Aim 2. Identify the genes involved in CBP1 transcriptional regulation. Insertional mutagenesis will be used to generate a library of mutants that will be screened for those that no longer regulate CBP1 normally. The most promising candidate regulatory genes will subsequently be used to identify coordinately regulated genes, potentially unraveling a network of genes related to CBP function or to other roles in pathogenesis.
PUBLIC HEALTH RELEVANCE: Histoplasmosis is a common fungal respiratory infection that is endemic in the midwestern U.S., where the causative agent (Histoplasma capsulatum) grows in the soil and is responsible for hundreds of thousands of new infections annually. This research plan is designed to probe the mechanisms by which these organisms proliferate inside host cells and affect the host immune response. Because the primary focus is on a virulence factor that is uniquely associated with a pathogenic fungus, the results have the potential to guide development of novel antifungal drugs.
描述(申请人提供):组织胞浆菌是一种典型的二相性真菌病原体,在温度诱导下从土壤中生长的霉菌形态转变为在肺巨噬细胞中建立感染的酵母菌形态。所有的二相性真菌都会在免疫功能低下的患者中引起最严重的疾病,但它们是主要的病原体,可以在缺乏任何明显免疫缺陷的宿主中引起严重问题。第一个被基因证实的致病因子是CBP,这是一种酵母相特异的分泌蛋白,对巨噬细胞的体外和体内增殖非常重要。解析CBP的三维结构显示出与皂苷B惊人的相似之处,皂苷B是一种哺乳动物蛋白质,参与膜处理和抗原呈递。虽然结构上的同源性强烈暗示CBP是第一个被发现的大而多样的皂苷样蛋白家族的真菌成员,但它在组织胞浆菌病中的确切机制作用仍未得到证实。这项赠款申请旨在评估CBP是否确实具有皂苷功能,并了解CBP1阶段特定调控的基础:具体目标1.定义CBP的皂苷样功能。这一目标的研究将首先测试CBP在结合脂质方面是否像皂苷一样发挥作用,无论是真菌还是哺乳动物,并将包括
结构-功能分析,以确定哪些CBP残基参与其中。CBP在CD1抗原递呈中的潜在作用也将被探索,类似于皂苷B的功能。特定目的2.确定参与CBP1转录调控的基因。插入突变将被用于产生一个突变体文库,该文库将被筛选出不再正常调控CBP1的突变体库。最有希望的候选调控基因随后将被用于识别协调调控的基因,潜在地解开与CBP功能或与发病机制中其他角色相关的基因网络。
公共卫生相关性:组织胞浆菌病是一种常见的真菌呼吸道感染,在美国中西部流行,致病菌(组织胞浆菌)生长在土壤中,每年导致数十万新感染。这项研究计划旨在探索这些微生物在宿主细胞内增殖并影响宿主免疫反应的机制。由于主要关注的是一种与致病真菌唯一相关的毒力因子,因此该结果有可能指导新型抗真菌药物的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM E GOLDMAN其他文献
WILLIAM E GOLDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM E GOLDMAN', 18)}}的其他基金
The evolution of virulence in the fungal pathogen Histoplasma
真菌病原体组织胞浆菌毒力的进化
- 批准号:
10210742 - 财政年份:2021
- 资助金额:
$ 18.5万 - 项目类别:
Evaluating the Role of Neutrophils in the Progression of Pneumonic Plague
评估中性粒细胞在肺鼠疫进展中的作用
- 批准号:
9412118 - 财政年份:2017
- 资助金额:
$ 18.5万 - 项目类别:
Discovering Histoplasma factors required for initial macrophage interaction
发现初始巨噬细胞相互作用所需的组织胞浆菌因子
- 批准号:
9243585 - 财政年份:2016
- 资助金额:
$ 18.5万 - 项目类别:
Early Events in the Pathogenesis of Pneumonic Plague
肺鼠疫发病机制的早期事件
- 批准号:
8443017 - 财政年份:2013
- 资助金额:
$ 18.5万 - 项目类别:
Role and Regulation of a Molecular Mimic in Histoplasma Pathogenesis
分子模拟物在组织胞浆菌发病机制中的作用和调节
- 批准号:
8415503 - 财政年份:2012
- 资助金额:
$ 18.5万 - 项目类别:
Molecular Mechanisms of Histoplasma Pathogenesis
组织胞浆菌发病机制的分子机制
- 批准号:
8297410 - 财政年份:2011
- 资助金额:
$ 18.5万 - 项目类别:
ROLE OF CALCIUM-BINDING PROTEIN AND FUNCTION IN LUNG DISEASE
钙结合蛋白的作用及其在肺部疾病中的功能
- 批准号:
7953952 - 财政年份:2009
- 资助金额:
$ 18.5万 - 项目类别:
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 18.5万 - 项目类别:
Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
- 批准号:
2898887 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
- 批准号:
22H02216 - 财政年份:2022
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
- 批准号:
22K05337 - 财政年份:2022
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
- 批准号:
2753345 - 财政年份:2022
- 资助金额:
$ 18.5万 - 项目类别:
Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
- 批准号:
20H03533 - 财政年份:2020
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
- 批准号:
2456629 - 财政年份:2020
- 资助金额:
$ 18.5万 - 项目类别:
Studentship
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
- 批准号:
19K05738 - 财政年份:2019
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
- 批准号:
2107517 - 财政年份:2018
- 资助金额:
$ 18.5万 - 项目类别:
Studentship